Skip to Content Facebook Feature Image

Fiji businesses seek greater market access via China's import expo

China

China

China

Fiji businesses seek greater market access via China's import expo

2025-11-10 22:13 Last Updated At:11-11 02:17

Businesses from the Pacific island nation of Fiji view the 8th China International Import Expo (CIIE) in Shanghai as a significant opportunity to expand market access and gain greater market share of the Chinese market through showcasing their best and most sought-after products.

The expo, which closed on Monday after a six-day run, has set a new record in terms of its scale, with the participation of over 4,100 exhibitors from 155 countries, regions, and international organizations.

Launched in 2018 as the world's first national-level import-themed expo, the CIIE is seen as a reflection of China's commitment to opening its market wider and sharing its growth opportunities with the world.

A few months ago, Fiji began preparing for the CIIE as a "full attendance" participant, and this year, the country specifically invited several international students studying in China to join in the preparations. Young Fijian Apenisa was fortunate to be among them.

Although it was his first time at the CIIE, Apenisa seemed like a seasoned veteran of the event. He spoke confidently about the products, making it hard to believe that he had only been studying Chinese for a year.

"I have been in China for a year. I like Chinese cuisine. I enjoy Chinese history. I like the Chinese people," he said in Chinese.

Apenisa was able to come to China through a dedicated program at Liaocheng University in east China's Shandong Province for students from Pacific Island countries.

"They are studying in universities and coming here. The CIIE gives them also an opportunity to go into business later," said Amelia Cobona, the second secretary of the Fijian Embassy in China.

In previous editions, Fiji has showcased a variety of signature products, with expanded Chinese market access translating into higher revenues for local enterprises. This year, the new product displays and the participation of international students, who serve as a cultural bridge between the two countries, have injected new energy into the Fijian booth.

"Now there are about 126 customers that came today from Fiji to bring our products here in China. It provides a lot of opportunities for especially the Fijian products to be broadcasted worldwide in bigger markets," said Apenisa.

"It's good that the products are here because here in CIIE, it creates the visibility. So you actually see the people coming to the booth, whether you are big or you are small. The Chinese government through CIIE has offered countries like ours that wonderful opportunity to come here, participate in person, and this is the place to be," Cobona said.

Fiji businesses seek greater market access via China's import expo

Fiji businesses seek greater market access via China's import expo

While its biomedical innovation has demonstrated vigorous momentum in recent years, China is providing better and more affordable therapeutic solutions to meet global needs, Eric Tse, CEO of Sino Biopharm, said in a recent interview with China Global Television Network (CGTN) on the sidelines of the ongoing annual meeting of the World Economic Forum (WEF) in Davos, Switzerland.

He emphasized that China is emerging as a key player in global biopharmaceutical innovation.

"I think China has definitely taken a much bigger part of the role in terms of global innovation development. We can see that China's data really rise from 5 percent of having innovative [products] into past 50 percent. Last year, I think the deals right now are rising from the top 10 out-licensing deals raised from in the past, maybe zero number right now, it's like half of them around Chinese companies. I think this really came out from how our talent dividends really drove our innovation going forward. And then, I think in the future, in the coming years, there will be more and more China-developed assets -- or not only fast-follower drugs but innovative drugs and products, that will be going forward. We're anticipating a very good 2026 or even 2027," said Eric Tse.

He further underscored that China's world-class biopharma clusters are driving medical innovations that benefit patients across the globe.

"China assets can really benefit the world. It's not only in the drug or the asset itself, but also on the infrastructure and ecosystem that it's building. Right now, it's like Shanghai, Beijing, Guangzhou, and let's say Jiangsu has a lot of cluster in terms of biotech pharmaceuticals. And, it is a, I think, given more and more attention in comparison in a decade ago -- a decade ago again, maybe you only have 5 percent of innovation globally. Right now, it's like that number went up by, let's say, at least four or five times. So, I think this is how we contribute to global med-needs and therapies, and having patients to access faster and better and more affordable therapies," he said.

Under the theme "A Spirit of Dialogue," the five-day 2026 WEF annual meeting is running in Davos through Friday. About 3,000 leaders and experts from around the world are gathering to discuss five pressing global challenges, including enhancing cooperation, unlocking new sources of growth and deploying innovation at scale and responsibly.

China's biotech clusters fuel better, affordable therapies for worldwide needs: insider

China's biotech clusters fuel better, affordable therapies for worldwide needs: insider

China's biotech clusters fuel better, affordable therapies for worldwide needs: insider

China's biotech clusters fuel better, affordable therapies for worldwide needs: insider

Recommended Articles